The FeCl3 induced thrombosis model in mice is described herein. A method to monitor thrombus growth by intravital microscopy observation on a mesenteric vessel and by blood flow measurement in the carotid artery is presented.
Severe thrombosis and its ischemic consequences such as myocardial infarction, pulmonary embolism and stroke are major worldwide health issues. The ferric chloride injury is now a well-established technique to rapidly and accurately induce the formation of thrombi in exposed veins or artery of small and large diameter. This model has played a key role in the study of the pathophysiology of thrombosis, in the discovery and validation of novel antithrombotic drugs and in the understanding of the mechanism of action of these new agents. Here, the implementation of this technique on a mesenteric vessel and carotid artery in mice is presented. The method describes how to label circulating leukocytes and platelets with a fluorescent dye and to observe, by intravital microscopy on the exposed mesentery, their accumulation at the injured vessel wall which leads to the formation of a thrombus. On the carotid artery, the occlusion caused by the clot formation is measured by monitoring the blood flow with a Doppler probe.
The study of the mechanisms involved in the development of thrombosis and the evaluation of the effectiveness of anti-thrombotic drugs requires well established experimental animal models. Large animal models were the first to be used as they provide large vessels more similar to humans than rodents1. However, high cost, the larger facilities required and the difficulty in manipulating them genetically are major drawbacks to their use and large animals are now limited to late preclinical studies once preliminary tests on rodents have given conclusive results2. With wide availability of transgenic and knockout strains and their small size that minimizes the quantity of antithrombotic drugs required for in vivo testing, mice are mainly used for thrombosis research. Therefore, several models of thrombotic disorders have been developed in mice3.
Many established thrombosis models disrupt the intima layer of the vessel wall, followed by the exposure of the sub endothelial extracellular matrix to the blood flow inducing the formation of blood clots4. The thrombi may result from the exposure of collagen which triggers platelets activation or/and from the exposure of tissue factor which activates the coagulation cascade5. Several techniques are then employed to achieve the initial vessel injury. Pierangeli et al. developed a mechanical disruption model with a microsurgery tool on the femoral vein6. Kikushi et al. described a model which consists in the administration of a photo reactive compound (Rose Bengal) which accumulates in the lipid bilayer of endothelial cells followed by the specific excitation of the vessel wall of interest with green light (540 nm)7. The injury can also be induced by a short high-intensity pulse laser illumination8. Another technique firstly established on the carotid artery of rats consists in the topical application of ferric chloride (FeCl3)9. In this case, the vessel denudation results from free radicals generated by FeCl3 which causes lipid peroxidation and destruction of endothelial cells10. The injury induces the expression of several adhesion molecules triggering platelet adhesion and aggregation as well as leukocytes recruitment. It has been demonstrated that leukocytes, particularly neutrophils, play a crucial role in the activation of the blood coagulation cascade leading to thrombosis11. This method is well suited to reproduce the coagulation cascade; investigators must keep in mind that, in this mouse model, thrombosis is typically induced in healthy vessels whereas thrombosis in humans is mainly occurring in diseased e.g. atherosclerotic vessels.
As this model is very simple to implement and is also effective in mice, it is now the mostly used thrombosis model for small animal in vivo studies. In addition, this technique offers the possibility to induce the formation of thrombi in a variety of vessels. Target vessels can be arteries or veins of large diameter (carotid, femoral, vena cava) or small diameter (mesentery, cremaster)12–14. More recently, it was also used on the proximal middle cerebral artery to develop a model of stroke15. The thrombosis formation may be directly observed by intravital microscopy after fluorescent labeling of platelet and leukocytes or monitored by measuring the blood flow decrease with a temperature probe or a Doppler probe12,16,17. Several parameters such as occlusion time, thrombus formation time or thrombus size may then be investigated. The physiological differences between the vessels investigated result in significant variations in the thrombi obtained. Therefore, investigators usually select the target vessel according to the parameters they want to measure and/or the disease setting they want to investigate. Typically, the model on the carotid artery is more relevant for research on atherothrombosis related to myocardial infarction or stroke whereas studies on the vena cava are more relevant for research on deep venous thrombosis. The accessibility of the different vessels also determines the method used to measure thrombus growth. For instance, the mesenteric vessels are easy to access making this model well suited for intravital microscopic observation and the study of the dynamics of thrombus formation. The carotid artery is less accessible but bigger enabling blood flow measurements and provide an excellent model to study occlusive thrombosis.
The ferric chloride induced thrombosis model has provided tremendous progress in the understanding of this pathology. It has been used in many studies focusing on the role of von Willebrand factor in thrombosis formation18,19. Combined with genetic modification techniques, it has allowed the identification of many specific gene involved in thrombotic disorders. Lamrani et al. for example have shown that a knock-in of the JAK2V617F gene is associated with an accelerating formation of unstable clot20. Zhang et al. have investigated the physiological implication of the P2Y12 platelet receptor and demonstrated that transgenic mice overexpressing specifically this receptor in platelets only, displayed a more rapid and stable thrombus formation in mesenteric artery injured with FeCl321. The crucial role of Tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA) in the fibrin degradation process has also been investigated in this method22. Furthermore this model also provides a simple and accurate way of testing the fibrinolytic capacities of many novel drugs in vivo. For instance, Wang et al. have used this model for the preclinical validation of a novel recombinant plasminogen activator targeted against activated platelets23. This method also enabled the validation of therapeutic proteins isolated from the salivary of ticks, vampire bats, and mosquitos or from the venom of snakes with specific identification of the target24-27. These examples demonstrate the versatility of the ferric chloride model. In this article, we focus on two methods and study ferric chloride induced thrombosis on two different vessel type; mesenteric vessel and carotid artery.
All experiments involving animals were approved by the Alfred Medical Research and Education Precinct Animal Ethics Committee (E/1534/2015/B). All surgical manipulations were performed under full anesthesia and the animals did not experience pain at any stage. All experiments described are non-recovery.
1. Preparation
2. Mesentery Arteriole Thrombus Formation Observed by Intravital Microscopy
3. Carotid Artery Thrombus Formation Assessed by Blood Flow Velocity Measurement
The fluorescent intravital microscopy observation of the mesentery will reveal the accumulation of Rhodamine 6G labeled platelets and leukocytes along the vessel wall injured by FeCl3. The progressive formation of a partial thrombus is monitored in a 200 µm mesentery vessel (Figure 1). A thrombus slowly appears and is clearly identifiable after the first minute of exposure to FeCl3 (Figure 1, t = 60 sec). 40 sec after the removal of the filter paper soaked with FeCl3, the thrombosis rapidly progresses and is finally present on the wall of the whole vessel section observed (Figure 1, t = 100 sec).
Figure 1: Thrombus Growth Observed by Fluorescent Intravital Microscopy on a Mesentery Vessel. Images were taken at 15 sec, 60 sec and 100 sec after the deposition of the filter paper soaked with 6% (w/v) FeCl3 solution. The filter paper was removed after 60 sec of exposure. Leukocytes and platelets were labeled through pre-injection of Rhodamine 6G (0.5% w/v). Red arrows indicate platelets/leukocytes aggregates. Scale bar 200 µm. Please click here to view a larger version of this figure.
An intra-carotid thrombus is induced by the application of a filter paper soaked in FeCl3 solution around an isolated carotid artery and the changes in blood flow downstream of the injury is recorded with a Doppler flow probe (Figure 2). An overall constant blood flow around 1.1 ml/min is measured in the non-injured carotid artery. After a 3 min exposure of the vessel with a filter paper soaked in 4% (w/v) FeCl3 solution, an occlusive thrombus is obtained with an occlusion time of 13 min and 30 sec after the beginning of the exposure. After a 3 min exposure with a filter paper soaked in 6% (w/v) FeCl3, an occlusive thrombus is obtained with an occlusion time of 9 min and 30 sec after the beginning of the exposure.
Figure 2. Representative Recordings of Blood Flow through the Carotid Artery after FeCl3 Injury. Blood flow was measured with a Doppler flow probe placed on the carotid artery just downstream of the filter paper soaked with 4% (w/v) or 6% (w/v) FeCl3. The filter paper was removed after 3 min of exposure. As a control blood flow was obtained by measuring the healthy carotid artery.
The ferric chloride induced thrombosis model is an excellent research tool. As shown in this study, it is extremely easy to implement and when used in combination with intravital microscopy or Doppler flowmeter, it provides a good real-time monitoring of thrombus formation. Adjusting the time exposure and the concentration of FeCl3, it also offers the possibility to produce either non-occlusive or occlusive thrombi.
However, this method also has some limitations. In the carotid artery, the major drawback is that although the occlusion time can effectively be modified, the reproducibility of the model remains too weak to precisely control thrombus size and growth rate10. Several groups have worked on a standardization of the model28,29. Owens et al. suggested that reliable and reproducible occlusion time may be obtained with practice and by reducing all the variation factors such as the age of the mice, the genetic background of the mice, the anesthesia utilized, the technique for the ferric chloride exposition and the concentration of the ferric chloride solution28. The Doppler probe itself also has some limitations with a certain degree of background signal present which can affect the determination of the occlusion. The blood flow may also be altered by the formation of unstable thrombi.
On the mesenteric vessel, the reproducibility may be affected by the size of the vessel that varies more than the carotid arteries and the presence of fat that may decreases the extent of the injury. It has been reported that the thrombi obtained differ according to the size of the vessel wall lesion which may restrain to endothelium shedding or also affect the smooth muscle cells of the media layer30. The laser irradiation model constitutes a good alternative of the ferric chloride model which provides a better reproducibility8. However, it is limited to small vessels that are transparent enough to enable the penetration of the laser. It should be also noticed that in this model, endothelial cells are destroyed after the ferric chloride application and it is therefore not suitable for studies on the role of endothelial cells. However, it is possible to replace the ferric chloride by calcium ionophore to obtain a weaker injury, restricted to the activation of the endothelium31.
Another limitation of this model is that it is not suitable to study long-term evolution of the disease. To fulfill this requirement, Boulaftali et al. have developed dorsal skinfold chambers which enable the monitoring of the same thrombus over several weeks32. This technique is especially well suited to examine the effects of thrombolytic drugs according to the thrombus maturity. In this study, the clot aging was found to impair the lytic action of a recombinant form of tissue plasminogen activator, which is currently the gold standard of thrombolytic drugs for human use.
Despite some drawbacks that must be taken in consideration, the FeCl3 model is relevant to the study of human thrombosis. The composition of the obtained thrombi has been analyzed on histological section and the presence of platelets, fibrin and red blood cells have been identified in the intra-carotid thrombi33. Besides, since atherothrombotic disorder is assumed to be initiated by the oxydation of lipoproteins, inducing the vessel injury though an oxido-reduction reaction the FeCl3 model is more likely to mimic the pathophysiology of the human disease than a mechanical, photo-chemical or laser induced injury34.
The thrombus formed though ferric chloride has also been described to be sensitive to both anticoagulant and anti-platelet drugs. Heparin and Clopidogrel for instance have been reported to extend the occlusion time of thrombi formed in the carotid artery29. The administration of a recombinant form of Hirudin has significantly prolonged the thrombus formation time on the mesentery microvasculature17. Therefore, the ferric chloride model provides excellent insights in thrombosis and is a highly relevant tool for the preclinical validation of new thrombolytic, anticoagulant and anti-platelet drugs.
The authors have nothing to disclose.
The authors would like to acknowledge technical support from Joy Yao and Dr. Karen Alt, as well as funding from the NHMRC and NHF.
Whatman chromatography paper | GE Healthcare | 3030917 | |
Iron (III) chloride 40 % (w/v) | VWR | 24212.298 | |
Rhodamine 6G | Sigma | R4127 | |
Inverted microscope | Olympus | IX81 | |
Digital black-and-white camera | Olympus | XM10 | |
Doppler flowmeter | Transonic | TS420 | |
Nano-doppler flow probe | Transonic | 0.5 PBS | |
Ketamine | Hospira | 0409-2051-05 | |
Xylazine (Rampun) | Bayer | 75313 | |
Petri dish | Sarstedt | 82.1472 | |
Insulin syringe (29 G) | BD Ultra-Fine | 326103 | |
Cotton tipped applicators | BSN medical | 211827A | |
Dynek dysilk sutures | Dynek Pty Ltd | CS30100 | |
Dulbecco's phosphate buffer saline (PBS) | Gibco life technologies | 21600-069 | |
Heating pad | Kirchner | T60 |